Berry Oncology (China)

242 papers and 4.7k indexed citations

About

In recent decades, authors affiliated with Berry Oncology (China) have published 242 papers, which have received a total of 4.7k indexed citations. Scholars at this organization have produced 74 papers in Molecular Biology, 74 papers in Genetics and 63 papers in Pediatrics, Perinatology and Child Health on the topics of Prenatal Screening and Diagnostics (60 papers), Cancer Genomics and Diagnostics (54 papers) and Lung Cancer Treatments and Mutations (45 papers). Their work is cited by papers focused on Molecular Biology (1.5k citations), Genetics (1.4k citations) and Pediatrics, Perinatology and Child Health (1.4k citations). Authors at Berry Oncology (China) collaborate with scholars in China, United States and Australia and have published in prestigious journals including Cell, Nature Communications and Journal of Clinical Oncology. Some of Berry Oncology (China)'s most productive authors include David S. Cram, Jianguang Zhang, Zhixi Tian, Haikuan Zhang, Yanting Shen, Mengnan Xu, Lingqian Wu, Zheng Wang, Zhuo Song and Miao Shi.

In The Last Decade

Berry Oncology (China)

223 papers receiving 4.7k citations

Fields of papers published by authors at Berry Oncology (China)

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers affiliated with Berry Oncology (China) at the time of their publication. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers affiliated with Berry Oncology (China) at the time of their publication.

Countries citing scholars working at Berry Oncology (China)

Since Specialization
Citations

This map shows the geographic impact of research produced by authors working at Berry Oncology (China). It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by papers produced at Berry Oncology (China) with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Berry Oncology (China) more than expected).

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar’s output or impact.

Explore institutions with similar magnitude of impact

Rankless by CCL
2026